Benitec Biopharma Ltd Stock Market Value
| BNTC Stock | USD 10.09 0.36 3.70% |
| Symbol | Benitec |
Benitec Biopharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Benitec Biopharma. If investors know Benitec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Benitec Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.51) | Revenue Per Share 0.003 | Quarterly Revenue Growth 0.125 | Return On Assets (0.50) | Return On Equity (0.92) |
The market value of Benitec Biopharma is measured differently than its book value, which is the value of Benitec that is recorded on the company's balance sheet. Investors also form their own opinion of Benitec Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Benitec Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Benitec Biopharma's market value can be influenced by many factors that don't directly affect Benitec Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Benitec Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Benitec Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Benitec Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Benitec Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Benitec Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Benitec Biopharma.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Benitec Biopharma on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Benitec Biopharma Ltd or generate 0.0% return on investment in Benitec Biopharma over 30 days. Benitec Biopharma is related to or competes with Bio Path, Capricor Therapeutics, NextCure, Aileron Therapeutics, Zura Bio, ZyVersa Therapeutics, and Apollomics. Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines More
Benitec Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Benitec Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Benitec Biopharma Ltd upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.57 | |||
| Information Ratio | 0.0294 | |||
| Maximum Drawdown | 29.78 | |||
| Value At Risk | (4.52) | |||
| Potential Upside | 7.89 |
Benitec Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Benitec Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Benitec Biopharma's standard deviation. In reality, there are many statistical measures that can use Benitec Biopharma historical prices to predict the future Benitec Biopharma's volatility.| Risk Adjusted Performance | 0.0533 | |||
| Jensen Alpha | 0.246 | |||
| Total Risk Alpha | (0.52) | |||
| Sortino Ratio | 0.0386 | |||
| Treynor Ratio | 1.75 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Benitec Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Benitec Biopharma Backtested Returns
Benitec Biopharma appears to be moderately volatile, given 3 months investment horizon. Benitec Biopharma secures Sharpe Ratio (or Efficiency) of 0.0613, which signifies that the company had a 0.0613% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Benitec Biopharma Ltd, which you can use to evaluate the volatility of the firm. Please makes use of Benitec Biopharma's Mean Deviation of 3.28, risk adjusted performance of 0.0533, and Downside Deviation of 3.57 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Benitec Biopharma holds a performance score of 4. The firm shows a Beta (market volatility) of 0.15, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Benitec Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Benitec Biopharma is expected to be smaller as well. Please check Benitec Biopharma's sortino ratio, skewness, period momentum indicator, as well as the relationship between the potential upside and rate of daily change , to make a quick decision on whether Benitec Biopharma's price patterns will revert.
Auto-correlation | -0.74 |
Almost perfect reverse predictability
Benitec Biopharma Ltd has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Benitec Biopharma time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Benitec Biopharma price movement. The serial correlation of -0.74 indicates that around 74.0% of current Benitec Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.74 | |
| Spearman Rank Test | 0.61 | |
| Residual Average | 0.0 | |
| Price Variance | 0.13 |
Benitec Biopharma lagged returns against current returns
Autocorrelation, which is Benitec Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Benitec Biopharma's stock expected returns. We can calculate the autocorrelation of Benitec Biopharma returns to help us make a trade decision. For example, suppose you find that Benitec Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Benitec Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Benitec Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Benitec Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Benitec Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
Benitec Biopharma Lagged Returns
When evaluating Benitec Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Benitec Biopharma stock have on its future price. Benitec Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Benitec Biopharma autocorrelation shows the relationship between Benitec Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Benitec Biopharma Ltd.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Benitec Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Benitec Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Benitec Biopharma Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Benitec Biopharma Ltd Stock:Check out Benitec Biopharma Correlation, Benitec Biopharma Volatility and Benitec Biopharma Alpha and Beta module to complement your research on Benitec Biopharma. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Benitec Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.